2m 2m 2m 2m 2m 2m 2m
Accuray (ARAY)
NASDAQ
$0.28+$0.02 (+5.91%)
Price as of Oct 02, 2026 7:30 PM EDT- $31.9MMarket Cap
- -83.81%1-Year Change
- Medical DevicesIndustry
Accuray (ARAY)
$0.28+$0.02 (+5.91%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 43.0M -57.70% | 101.6M -77.26% | 446.6M -0.24% | 447.6M +4.12% | |
Cost of Revenue | 41.0M -44.91% | 74.4M -75.49% | 303.6M +3.40% | 293.6M +8.78% | |
Gross Profit | 111.5M -24.16% | 147.0M +2.83% | 142.9M -7.17% | 154.0M -3.75% | |
Sales and Marketing Expense | 38.6M -10.95% | 43.3M +1.63% | 42.6M -7.71% | 46.2M -7.02% | |
Research and Development Expense | -1.3M -12.69% | -1.5M -97.02% | -49.7M -12.95% | -57.1M -1.08% | |
Depreciation and Amortization Expense | 7.9M +29.14% | 6.2M +4.15% | 5.9M +30.44% | 4.5M -17.88% | |
Total Operating Expenses | 137.9M -0.89% | 139.1M -2.31% | 142.4M -6.04% | 151.6M -0.15% | |
Operating Profit | -26.4M -437.31% | 7.8M +1,455.36% | 504,000 -78.84% | 2.4M -70.77% | |
Interest Income | 819,000 -31.29% | 1.2M N/A | N/A N/A | N/A N/A | |
Interest Expense | -825,000 +21.68% | -678,000 -94.17% | -11.6M +9.33% | -10.6M +30.79% | |
Interest Income and Expense and Net | -6,000 -101.17% | 514,000 +104.42% | -11.6M +9.33% | -10.6M +30.79% | |
Total Nonoperating Income and Expense | 5.0M +796.42% | 559,000 +122.03% | -2.5M -78.39% | -11.7M +13.00% | |
Income before Taxes | -47.2M -4,266.49% | 1.1M +109.59% | -11.8M +74.13% | -6.8M +239.06% | |
Income Taxes | 1.9M -28.59% | 2.7M -26.85% | 3.7M +49.48% | 2.5M -25.50% | |
Extraordinary Items | 2.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -49.2M +2,992.02% | -1.6M -89.77% | -15.5M +67.51% | -9.3M +73.56% | |
Net Income from Continuing Operations Applicable to Common | -47.2M -4,266.49% | 1.1M +109.59% | -11.8M +74.13% | -6.8M +239.06% | |
Basic EPS and Net Income | -0.40 +1,900.00% | -0.02 -87.50% | -0.16 +60.00% | -0.10 +66.67% | |
Diluted EPS and Net Income | -0.40 +1,900.00% | -0.02 -87.50% | -0.16 +60.00% | -0.10 +66.67% | |
Basic Weighted Average Shares | 122.6M +19.33% | 102.8M +4.58% | 98.3M +3.57% | 94.9M +3.03% | |
Diluted Weighted Average Shares | 122.6M +19.33% | 102.8M +4.58% | 98.3M +3.57% | 94.9M +3.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 40.6M -29.25% | 57.4M -16.27% | 68.6M -23.30% | 89.4M +0.75% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 40.6M -29.25% | 57.4M -16.27% | 68.6M -23.30% | 89.4M +0.75% | |
Total Current Assets | 287.8M -9.35% | 317.5M -1.79% | 323.2M -4.38% | 338.0M -3.66% | |
Accumulated Depreciation | 80.6M +3.47% | 77.9M +5.74% | 73.7M -6.21% | 78.6M -0.82% | |
Property and Plant and Equipment and Net | 27.3M -4.68% | 28.7M +15.68% | 24.8M +18.39% | 20.9M +64.97% | |
Total Long-Term Assets | 30.6M +25.20% | 24.4M +36.17% | 17.9M -10.73% | 20.1M +4.21% | |
Total Assets | 443.7M -5.65% | 470.2M +0.34% | 468.6M -2.21% | 479.2M +1.35% | |
Income Taxes Payable | 331,000 -65.98% | 973,000 -19.32% | 1.2M N/A | N/A N/A | |
Total Short-Term Debt | 1.5M -88.22% | 12.7M +64.18% | 7.8M +35.57% | 5.7M -33.19% | |
Total Current Liabilities | 191.4M -0.61% | 192.6M -1.38% | 195.3M -1.70% | 198.6M -4.89% | |
Total Long-Term Debt | 146.4M +18.24% | 123.8M -24.70% | 164.4M -4.17% | 171.6M -0.20% | |
Total Long-Term Liabilities | 5.5M +6.14% | 5.2M -30.17% | 7.4M +58.05% | 4.7M +24.73% | |
Total Liabilities | 402.0M +3.32% | 389.1M -8.14% | 423.5M -0.47% | 425.6M +1.40% | |
Retained Earnings | -568.5M +9.47% | -519.3M +0.31% | -517.7M +3.10% | -502.1M +1.95% | |
Total Stockholders Equity | 41.7M -48.63% | 81.2M +80.04% | 45.1M -15.98% | 53.7M +0.88% | |
Total Shares Outstanding | 119.4M +6.03% | 112.6M +12.42% | 100.2M +3.79% | 96.5M +3.25% | |
Cash Flow | |||||
Cash from Operating Activities | -7.0M -344.09% | 2.9M +124.03% | -11.9M -176.61% | 15.5M +747.46% | |
Capital Expenditures | 5.9M +37.20% | 4.3M +18.63% | 3.6M -71.45% | 12.6M +167.42% | |
Cash from Investing Activities | -12.3M +44.07% | -8.5M +136.68% | -3.6M -71.60% | -12.7M +168.84% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.0M +264.09% | -4.3M +7.62% | -4.0M +87.07% | -2.1M -86.26% | |
Financials Ratio | |||||
Gross Margin | 4.58% -82.86% | 26.72% -16.50% | 32.01% -6.95% | 34.40% -7.55% | |
Operating Margin | -61.54% -897.36% | 7.72% +6,736.49% | 0.11% -78.79% | 0.53% -71.92% | |
Return on Assets | -10.77% +3,076.63% | -0.34% -89.67% | -3.28% +68.25% | -1.95% +73.72% | |
Return on Equity | -80.08% +3,077.25% | -2.52% -92.00% | -31.49% +81.26% | -17.37% +98.21% | |
Revenue Growth | -57.70% -25.32% | -77.26% +32,705.14% | -0.24% -105.72% | 4.12% -51.48% | |
Current Ratio | 1.50 -8.80% | 1.65 -0.42% | 1.66 -2.73% | 1.70 +1.30% | |
Cash Ratio | 0.21 -28.82% | 0.30 -15.12% | 0.35 -21.97% | 0.45 +5.93% | |
Debt-to-Equity Ratio | 3.55 +110.84% | 1.68 -55.96% | 3.82 +15.58% | 3.30 -2.63% | |
Debt-to-Assets Ratio | 0.33 +14.81% | 0.29 -20.99% | 0.37 -0.68% | 0.37 -3.09% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow